Emergency Medicine Doctors in La Follette, TN Accepting Medicare

5 Emergency Medicine doctors found. Showing 1 - 5

Dr. Charles T Baker Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1200

Dr. Thomas Edwin Bishofberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1200    Fax: 865-693-4064

Elijah G Cline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1200    Fax: 865-291-3228

Ivy Lee Massengale, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1200

Barry A Stewart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 923 E Central Ave, La Follette, TN 37766 Phone: 423-907-1404

News Archive

Advanced microscopes determine structure of molecular complex implicated in several cancers

In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.

Audax Medical licenses novel TBL technology to fix broken bones from Brown

Here's the vision: an elderly woman comes into the emergency room after a fall. She has broken her hip. The orthopaedic surgeon doesn't come with metal plates or screws or shiny titanium ball joints. Instead, she pulls out a syringe filled with a new kind of liquid that will solidify in seconds and injects into the break. Over time, new bone tissue will take its place, encouraged by natural growth factors embedded in the synthetic molecules of the material.

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature.

InterMune seeks FDA marketing approval for pirfenidone

InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.

High Court decision imminent on health law's birth control mandate

Also pending is a decision regarding free speech arguments against a Massachusetts law that creates a buffer zone around abortion clinics to keep protesters from patients.

Read more Medical News

› Verified 4 days ago